Morphine formulations for use by electromotive administration

Details Morphine formulations for use by electromotive administration Morphine formulations for use by electromotive administration

1994-07-18

1997-03-04

Kight, John

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

546 44, 546 45, 604 20, A61K 3144, C07D47100, C07D48900, A61N 130

Patent

active

056079400

ABSTRACT:
A morphine formulation for use by electromotive administration comprising morphine citrate salts of the formula:

REFERENCES:
patent: 4248855 (1981-02-01), Blank
patent: 4626539 (1986-12-01), Aungst et al.
patent: 4747819 (1988-05-01), Phipps et al.
patent: 4879297 (1989-11-01), Mahjour et al.
patent: 4915685 (1990-04-01), Petelenz et al.
patent: 4968297 (1990-11-01), Jacobsen et al.
patent: 4979938 (1990-12-01), Stephen et al.
patent: 5057072 (1991-10-01), Phipps
patent: 5387420 (1995-02-01), Mitchell
J. Pain Symptom Manage. vol. 7, No. 1, 1992, pp. 27-33. M. A. Ashburn et al, "Iontophoretic Delivery of Morphine for Postoperative Analgesia".
J. Pain Symptom Manag. vol. 7, No. 3, 1992, pp. 160-162. W. S. Nimmo "Novel Delivery Systems: Electrotransport".
Pharm. Res. vol. 5, No. 7, 1988, pp. 443-446 P. Glikfeld et al., "A New System for In Vitro Studies of Iontophoresis".

Affiliated with

Also associated with

Rating

Morphine formulations for use by electromotive administration does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Morphine formulations for use by electromotive administration, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Morphine formulations for use by electromotive administration will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2146114